November 16 2021 – Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer CBD and hemp products, today announced that it has signed a national distribution agreement with Southern Glazer’s Wine & Spirits (“Southern Glazer’s”), the world’s largest distributor of beverage alcohol. The Agreement will bring Curaleaf’s lineup of products from their eponymous Hemp and Select CBD product lines into Southern Glazer’s distribution network.

The distribution relationship combines Curaleaf’s expertise in creating high-quality non-psychoactive hemp products with Southern Glazer’s national scale, unmatched route-to-market  capabilities, state-of-the-market sales team and its industry-leading Proof® e-commerce platform, bringing operating efficiencies that will drive growth within Curaleaf’s family of CBD products.

Curaleaf Hemp and Select currently offer a broad range of CBD products with consumer-friendly formats and price points. The brands look forward to introducing new innovations to both ancillary lines with confections and beverages that feature minor cannabinoids like CBN and CBG, allowing consumers to personalize their CBD experiences as they continue to learn which products will work best for their unique needs.

“At Curaleaf, we are as committed to innovation and setting the highest possible standards for product quality as we are committed to customer accessibility – and our success lies not only in our ability to provide exceptional CBD-infused products, but to distribute them to the finest retail stores for safe, easy and reliable access to consumers around the country,” said Patrick Larkin, SVP of Sales at Curaleaf.

“We are delighted to be joining forces with a world leading beverage distributor that shares our values around responsible distribution and pioneering a well regulated industry,” said Joseph Gennaro, VP of CBD, Health & Wellness at Curaleaf. “We value Southern Glazer’s expertise, efficiency and extensive network, particularly as we aim to open the consumer awareness funnel and fuel growth within our CBD business.”

“We are excited to add Curaleaf to our distribution network, as we are aligned on the future growth potential of CBD in the U.S. and, as such, are both investing significantly in the category,” said David Chaplin, Chief Growth Officer, Southern Glazer’s. “Southern Glazer’s best-in-class CBD sales and marketing capability is uniquely positioned to deliver the most effective route-to-market for Curaleaf and I am confident we can drive continued growth for their portfolio of products at retail locations across the U.S.”

“I look forward to working with Curaleaf to provide industry-leading sales and service execution across Southern Glazer’s markets,” added Kariff Rhooms, Vice President, SG Ventures and head of Southern Glazer’s CBD sales division. “We are confident that we have the expertise and experience to engage more consumers through our network of retail customers as we work with Curaleaf to continue to grow the CBD category.”

For more information, please visit CuraleafHemp.com and SelectCBD.com.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 111 dispensaries, 22 cultivation sites and over 30 processing sites, and employs more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.